Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway
- PMID: 11228049
- DOI: 10.1507/endocrj.47.739
Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway
Abstract
IGF-I regulates cell growth, differentiation, and survival in many cultured nerve cell lines. The present study was undertaken in the human neuroblastoma cell line, SH-SY5Y, to elucidate whether there are differences in the IGF-dependent signal transduction pathways that stimulate proliferation compared to those that induce differentiation. Quiescent SH-SY5Y cells were treated with IGF-I in the presence or absence of PD98059 (an inhibitor of MEK, a MAP kinase kinase) or LY294002 (an inhibitor of PI 3-kinase). Cell growth was assessed by measuring [3H]thymidine incorporation into DNA and cell number. Cell differentiation was assessed by measuring mRNA levels of NPY and neurite outgrowth. IGF-I both induced cell proliferation and differentiation. It stimulated tyrosine phosphorylation of the type I IGF receptor (IGF-IR) beta-subunit, IRS-I, IRS-2, and Shc, and these changes were associated with activation of Erk and Akt. PD98059 inhibited activation of Erk and LY294002 repressed activation of Akt in response to IGF-I, but did not affect tyrosine phosphorylation of the IGF-IR, IRS-1, IRS-2, or Shc. Each PD98059 and LY294002 inhibited IGF-I-dependent cell proliferation in a concentration-dependent manner. In contrast, each of these inhibitors only partially depressed NPY gene expression induced by IGF-I and slightly inhibited IGF-I-mediated neurite outgrowth; however, when both PD98059 and LY294002 were present, IGF-I-dependent NPY gene expression and neurite outgrowth were abolished completely. These results suggest that in these nerve cells, 1) the IGF-I signals through the MAP kinase pathway and PI-3 kinase pathway are independently essential to induce IGF-I-dependent growth, and 2) alternate activation of the MAP kinase pathway and PI 3-kinase pathway is sufficient for the cells to undergo IGF-I-dependent differentiation.
Similar articles
-
Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.J Biol Chem. 1998 Dec 18;273(51):34543-50. doi: 10.1074/jbc.273.51.34543. J Biol Chem. 1998. PMID: 9852124
-
Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.Endocrinology. 1998 Dec;139(12):4881-9. doi: 10.1210/endo.139.12.6348. Endocrinology. 1998. PMID: 9832424
-
Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.Biochem J. 2000 Jun 1;348 Pt 2(Pt 2):409-16. Biochem J. 2000. PMID: 10816436 Free PMC article.
-
IGF1 receptor signaling pathways.J Mol Endocrinol. 2018 Jul;61(1):T69-T86. doi: 10.1530/JME-17-0311. Epub 2018 Mar 13. J Mol Endocrinol. 2018. PMID: 29535161 Review.
-
The IRS-1 signaling system.Trends Biochem Sci. 1994 Jul;19(7):289-93. doi: 10.1016/0968-0004(94)90007-8. Trends Biochem Sci. 1994. PMID: 8048169 Review.
Cited by
-
Insulin and insulin-like growth factor resistance in alcoholic neurodegeneration.Alcohol Clin Exp Res. 2008 Sep;32(9):1630-44. doi: 10.1111/j.1530-0277.2008.00731.x. Epub 2008 Jul 8. Alcohol Clin Exp Res. 2008. PMID: 18616667 Free PMC article.
-
NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers.Front Oncol. 2021 Jun 25;11:669667. doi: 10.3389/fonc.2021.669667. eCollection 2021. Front Oncol. 2021. PMID: 34277416 Free PMC article.
-
Cathepsin Inhibition Prevents Autophagic Protein Turnover and Downregulates Insulin Growth Factor-1 Receptor-Mediated Signaling in Neuroblastoma.J Pharmacol Exp Ther. 2016 Feb;356(2):375-86. doi: 10.1124/jpet.115.229229. Epub 2015 Dec 10. J Pharmacol Exp Ther. 2016. PMID: 26660229 Free PMC article.
-
'The effect of neuropeptide Y1 receptor agonist on hypothalamic neurogenesis in rat experimental depression model'.Metab Brain Dis. 2024 Nov 22;40(1):39. doi: 10.1007/s11011-024-01445-1. Metab Brain Dis. 2024. PMID: 39576364
-
Effect of M2 Macrophage-Derived Soluble Factors on Proliferation and Apoptosis of SH-SY5Y Cells.Bull Exp Biol Med. 2021 May;171(1):45-48. doi: 10.1007/s10517-021-05169-5. Epub 2021 May 29. Bull Exp Biol Med. 2021. PMID: 34050417
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous